FDA Gives Emergency Authorization of Hydroxychloroquine Use

The Food And Drug Administration (FDA) issued an emergency authorization Sunday for hydroxychloroquine, a drug already used to treat malaria and other ailments, which has shown anecdotal efficacy against coronavirus.

The use of the drug — often paired with azithromycin — has not yet been proven in clinical trials to be effective against the disease. However, given reported success in a growing number of small, non-randomized studies; as well as testimonials from doctors and patients about the use of the “off-label” drug regimen, doctors are said to be prescribing the treatment to patients who are severely ill. Anecdotally, many doctors are taking it prophylactically.

The Department of Health and Human Services (HHS) issued a statement on Sunday:

The U.S. Food and Drug Administration (FDA) issued an Emergency Use Authorization (EUA) to BARDA to allow hydroxychloroquine sulfate and chloroquine phosphate products donated to the Strategic National Stockpile (SNS) to be distributed and prescribed by doctors to hospitalized teen and adult patients with COVID-19, as appropriate, when a clinical trial is not available or feasible.

Trump Says Ceasefire Has Been ‘Violated Numerous Times’ as Iran Threatens to Deploy ‘New Cards on the Battlefield’

‘Traitor’ Dem senator ripped after one-word reaction appears to cheer on Iran

Alert: 26 Christians Kidnapped in 8 Days by Muslims Fulani Terrorists in Nigeria

Hiker identified, popular trail closed after deadly fall at Utah’s Zion National Park

Byron Donalds cracks down on persistent border blind spot leaving US vulnerable to overstays

DOJ Reveals How Biden Weaponized the Government Against Anti-Abortion Activists

Suspect allegedly guns down deputy in ambush during routine call that rocked quiet town, police say

Trump Names New Acting Labor Secretary as Chavez-DeRemer Resigns

Ex-Trump ally MTG slams both sides of the political aisle: ‘Nothing ever changes’

Dem hopeful who co-founded Joe Rogan’s favorite jeans under fire for ‘Made in America’ claim

What to watch as Virginia voters decide high-stakes redistricting referendum

Trump pleads with Virginians to ‘just vote no’ on redistricting measure in telerally call

Another Democrat exits California’s crowded gubernatorial race weeks before the June 2 primary election

Chinese national arrested at JFK after allegedly photographing US military aircraft at Nebraska base

Louisiana Mass Murderer Who Killed 8 Children Previously Got Probation for Firing Gun Toward a School: Report

HHS also noted that it had “accepted 30 million doses of hydroxychloroquine sulfate donated by Sandoz, the Novartis generics and biosimilars division, and one million doses of chloroquine phosphate donated by Bayer Pharmaceuticals, for possible use in treating patients hospitalized with COVID-19 or for use in clinical trials.”

Earlier, the French government had approved similar drugs to treat the virus.

Amid concerns that the sudden interest in hydroxychloroquine could cause shortages, HHS noted: “Use of the donated medications is expected to help ease supply pressures for the drug, and the FDA is also working with manufacturers of chloroquine and hydroxychloroquine to increase production to ensure these drugs also remain available for patients dependent on them for treatment of malaria, lupus and rheumatoid arthritis.”